Sterile API Manufacturing You Can Build Your Pipeline On
Bharat Sterile specializes in sterile API manufacturing for critical-care therapeutic segments — combining aseptic processing expertise, WHO-GMP compliant infrastructure and rigorous sterility assurance.
Sterile API Manufacturing, Defined
Sterile API manufacturing is the process of producing active pharmaceutical ingredients that are completely free from viable microorganisms and suitable for use in injectable or other sterile dosage forms. Unlike standard API production, it requires controlled cleanrooms, validated aseptic processes and ongoing monitoring to prevent microbial, particle and endotoxin contamination during production.
At Bharat Sterile, sterile API manufacturing takes place in ISO-classified cleanrooms (Grades A, B, C and D), supported by lyophilization for heat-sensitive molecules, with our quality system following WHO-GMP requirements.
Why Sterile API Manufacturing Is Different
Manufacturing a sterile API is significantly more complex than producing a standard, non-sterile API — even trace microbial presence can compromise patient safety in injectable therapies. Our approach is built around four pillars.
Controlled Cleanrooms
Production takes place in ISO-classified Grade A, B, C and D cleanrooms, each following strict monitoring to control particles and microbes.
Aseptic Processing Expertise
Our aseptic processing capabilities maintain sterility throughout filtration, handling and filling stages, minimizing contamination risk at every touchpoint.
Lyophilization
For sterile APIs sensitive to heat or moisture, our lyophilization (freeze-drying) unit preserves molecular stability while maintaining sterility assurance.
Rigorous Testing
Every batch undergoes microbiological testing, HPLC/GC analysis and full release testing before dispatch, backed by a COA and complete batch traceability.
Sterile APIs We Manufacture
Dedicated sterile manufacturing support across four major therapeutic categories, each manufactured under protocols suited to its specific sterility, stability and impurity-control requirements.
Cephalosporins
Ceftriaxone, Cefuroxime, Ceftazidime, Cefepime, Cefoperazone and related sterile cephalosporin APIs used in broad-spectrum antibacterial therapies.
Carbapenems
Meropenem and Imipenem + Cilastatin, critical for treating multi-drug resistant bacterial infections.
Penicillins
Amoxicillin Sodium, Ampicillin Sodium, Benzyl Penicillin and Piperacillin/Tazobactam combinations.
Sterile PPIs
Pantoprazole Sodium, Omeprazole Sodium, Rabeprazole Sodium and Esomeprazole Sodium for injectable gastro-intestinal formulations.
How We Manufacture Sterile APIs
A step-by-step, contamination-controlled workflow from incoming material through processing, testing, packaging and dispatch.
-
1Raw Material Qualification
Vendor-qualified sourcing with thorough incoming material testing.
-
2Aseptic Processing
Manufacturing carried out under Grade A/B/C/D cleanroom conditions with HEPA-filtered airflow.
-
3Sterilization & Lyophilization
Sterile filtration and freeze-drying for heat-sensitive APIs.
-
4In-Process Quality Control
Continuous HPLC, GC and microbiological testing at every critical control point.
-
5Final Release Testing
Comprehensive release testing with full documentation and batch traceability.
-
6Packaging & Global Dispatch
GMP-compliant packaging designed to preserve sterility during transit to domestic and international partners.
Built to Meet Global Regulatory Expectations
Bharat Sterile's sterile API manufacturing operations follow WHO-GMP guidelines, supporting data integrity, environmental monitoring and audit readiness across every cleanroom grade. Our Pharmaceutical Quality System (PQS) is designed to reduce the risk of microbial, particulate and endotoxin contamination — a key requirement for any sterile API maker serving regulated global markets.
WHO-GMP
ISO 9001:2015
Full COA
Audit Ready
ZLD Plant
What Makes Us a Reliable Sterile API Partner
Specialized Focus
Unlike large multi-therapy CDMOs, our sterile API manufacturing capability is deeply focused on cephalosporins, carbapenems, penicillins and sterile PPIs — giving us deeper process expertise per molecule class.
WHO-GMP Compliant Facility
Purpose-built infrastructure at SICOP Kathua, Jammu & Kashmir, designed specifically for aseptic sterile API production.
Faster Partner Collaboration
As a focused, agile organization, Bharat Sterile offers quicker technical response and decision-making compared to large global networks.
Sustainable Manufacturing
Zero Liquid Discharge (ZLD) systems reflect our commitment to environmentally responsible sterile manufacturing.
Global Reach, Personal Partnership
Serving partners across 20+ countries while maintaining a direct, relationship-driven approach to every account.
Custom Sterile API Manufacturing Partnerships
Beyond our existing sterile API portfolio, Bharat Sterile welcomes enquiries for contract and custom sterile manufacturing. Our technical and regulatory teams collaborate with partners to assess feasibility, manage technology transfer and support scale-up for new sterile molecules — making us a manufacturing partner invested in your long-term success, not just a one-time supplier.
Ready to Partner With a Trusted Sterile API Manufacturer?
Whether you need a quote, technical documentation, or want to explore a long-term sterile API supply partnership, the Bharat Sterile team is ready to support your business.
Frequently Asked Questions About Sterile API Manufacturing
Sterile API manufacturing is the production of Active Pharmaceutical Ingredients that are completely free of viable microorganisms, manufactured under controlled cleanroom conditions for use in injectable and other sterile dosage forms.
Sterile API manufacturing requires ISO-classified cleanroom environments, validated aseptic processing and continuous environmental monitoring to prevent microbial, particulate and endotoxin contamination — controls that are not required for standard, non-sterile API production.
Bharat Sterile manufactures sterile Cephalosporins, Carbapenems, Penicillins and Proton Pump Inhibitors (PPIs), supporting critical-care and gastro-intestinal therapeutic segments.
Yes. Bharat Sterile's sterile API manufacturing facility at SICOP Kathua operates under WHO-GMP guidelines, with audit-ready systems and complete batch documentation.
Yes. Bharat Sterile offers custom and contract sterile manufacturing partnerships, including feasibility assessment, technology transfer and scale-up support for new molecules.
Bharat Sterile uses aseptic processing techniques, including sterile filtration and lyophilization, to manufacture sterile APIs while preserving molecular stability and sterility assurance.
You can contact Bharat Sterile directly through the Contact page to request a quote, Certificate of Analysis (COA), or other regulatory documentation.